|
US2003229004A1
|
|
Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitors
|
|
AU9647101A
|
|
High-throughput gene cloning and phenotypic screening
|
|
AU2001283226A1
|
|
Methods and compositions for inhibiting rad51
|
|
AU7811401A
|
|
Enhanced targeting of dna sequences by recombinase protein and single-stranded homologous dna probes using dna analog activation
|
|
AU7324501A
|
|
Modulators of trk protein activity, compositions and methods of use
|
|
US2004023213A1
|
|
Domain specific gene evolution
|
|
WO02058738A2
|
|
Use of rad51 inhibitors for p53 gene therapy
|
|
WO0159683A2
|
|
Integrated genomic services
|
|
AU2610301A
|
|
Recombinase mediated gene chip detection
|
|
WO0150847A2
|
|
Reca / rad51 recombinase-mediated production of recombinant organisms
|
|
EP1212087A1
|
|
Methods and compositions utilizing rad51
|
|
EP1204868A1
|
|
Cancer treatments and diagnostics utilizing rad51 related molecules and methods
|
|
WO0063365A1
|
|
Locked nucleic acid hybrids and methods of use
|
|
WO0056872A2
|
|
High-throughput gene cloning and phenotypic screening
|
|
US6576759B2
|
|
Antisense inhibition of RAD51
|
|
CA2339420A1
|
|
Domain specific gene evolution
|
|
US6524856B1
|
|
Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
|
|
US5929043A
|
|
Recombinase mediated DNA therapies
|
|
CA491373A
|
|
Timber joint construction in walls, panels, partitions; and prefabricated timbers therefor
|
